MACROGENICS INC. - CO

MacroGenics to Participate in Upcoming Investor Conferences

06 ноя 2024 16:30:00 Источник Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

05 ноя 2024 16:01:00 Источник Nasdaq GlobeNewswire

MacroGenics Announces Leadership Transition

30 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

29 окт 2024 16:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

24 сен 2024 09:46:10 Источник NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

23 сен 2024 10:42:43 Источник NetDania Notify

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

15 сен 2024 03:00:00 Источник Nasdaq GlobeNewswire

MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024

08 сен 2024 19:10:00 Источник Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

06 авг 2024 16:01:41 Источник Nasdaq GlobeNewswire

MacroGenics Provides Vobramitamab Duocarmazine Update

30 июл 2024 16:10:00 Источник Nasdaq GlobeNewswire

MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte

30 июл 2024 16:01:00 Источник Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conference

11 июн 2024 07:45:00 Источник Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

13 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

10 май 2024 10:01:03 Источник NetDania Notify

MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data

09 май 2024 16:01:13 Источник Nasdaq GlobeNewswire

MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call

03 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures

03 апр 2024 16:30:00 Источник Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress and 2023 Financial Results

07 мар 2024 16:01:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: MACROGENICS INC. - COMMON STOCK

06 мар 2024 10:28:25 Источник NetDania Notify

NetDania - New 12 months High: MACROGENICS INC. - COMMON STOCK

05 мар 2024 09:45:33 Источник NetDania Notify